RTN4 and metabolic syndrome: Recently, Duan group reported a 6-methyl flavone inhibitor [40], which can effectively inhibit Nogo-B expression in the liver to treat metabolic syndrome caused by glycolipid metabolism dysregulation, with a IC50 value of 15.85 μM.